Avidicure
Seed Round in 2025
Avidicure is a biotechnology company developing a dual agonistic, multifunctional antibody modality engineered for targeted cancer immunotherapy. Its AVC-Boosters are designed to engage immune cells with high avidity and to localize activation within tumors, enabling potent anti-tumor activity as monotherapy while reducing off-target effects. The approach aims to advance oncology therapies by combining immune engagement with tumor-specific activation to support immune responses and potentially improve safety profiles.
EAGLE RAILCAR SERVICES
Acquisition in 2025
EAGLE RAILCAR SERVICES is one of the nation's leading independent providers of railcar repair services.
ReliaQuest
Private Equity Round in 2025
ReliaQuest is a cybersecurity company based in Tampa, Florida, founded in 2007. It specializes in providing a cloud-native security platform called GreyMatter, which offers a comprehensive solution for minimizing data loss and business disruptions. The platform enhances visibility across Security Information and Event Management (SIEM), Endpoint Detection and Response (EDR), and multi-cloud environments, facilitating faster detection and response to security threats. By automating processes throughout the security lifecycle, ReliaQuest enables organizations to manage their security investments effectively and make informed decisions regarding their cybersecurity posture. The company's offerings are designed to protect enterprise environments from security breaches while ensuring compliance and enhancing overall security confidence.
Perfuze
Venture Round in 2025
Founded in 2018, Perfuze is a medical device company based in Galway, Ireland. It specializes in developing catheter-based aspiration technology designed to treat acute ischemic stroke efficiently and effectively.
TravelPerk
Series E in 2025
TravelPerk is a SaaS platform that simplifies business travel management. It offers integrated booking, reporting, and support for flights, hotels, and car rentals, ensuring compliance with company policies.
Cornerstone Robotics
Series C in 2025
Cornerstone Robotics develops medical robotic devices designed for precise surgical robotic systems. Their products feature multi-degree-of-freedom robotic arms, real-time imaging integration, and intuitive surgeon interfaces, enabling healthcare providers to perform advanced minimally invasive surgeries with greater control and consistency.
Scale Microgrid Solutions
Acquisition in 2025
Scale Microgrid Solutions, Inc. is a company that designs, builds, operates, and finances on-site power systems for commercial and industrial facilities across North America. Founded in 2016 and based in Ridgewood, New Jersey, the company specializes in multi-resource clean energy microgrids that support both daily operations and power outage scenarios. Its innovative offerings include the rapid response modular microgrid system, which optimizes solar photovoltaic energy, battery storage, and dispatchable generation. By providing fully-financed microgrid solutions, Scale Microgrid Solutions aims to deliver sustainable, reliable power while simplifying the microgrid development process for its customers.
XyloCor Therapeutics
Series B in 2025
XyloCor Therapeutics, Inc. is a biopharmaceutical company specializing in the development of gene therapies for cardiovascular diseases, particularly advanced coronary artery disease. Founded in 2013 and based in Newtown Square, Pennsylvania, the company focuses on innovative treatments aimed at addressing significant unmet medical needs. Its lead product candidate, XC001, is currently in clinical development for patients suffering from refractory angina, targeting individuals who have exhausted other treatment options. XyloCor's approach centers on stimulating the formation of new coronary blood vessels to enhance blood supply to areas of the heart that are inadequately perfused, thereby improving patient outcomes in those affected by heart failure and ischemic conditions. The company collaborates with Weill Cornell Medical College to advance its gene therapy technologies.
Tenpoint Therapeutics
Venture Round in 2024
Tenpoint Therapeutics is a biotechnology company dedicated to developing engineered cell-based therapies aimed at restoring vision for individuals affected by degenerative ocular diseases. The company leverages an innovative platform that includes in vivo reprogramming techniques, allowing for targeted delivery of therapeutic systems directly to the eye. This approach eliminates the need for systemic administration, which can improve treatment efficacy and patient outcomes. By focusing on vision restoration, Tenpoint Therapeutics strives to significantly enhance the quality of life for patients suffering from various eye conditions.
Noema Pharma
Series B in 2024
Founded in 2019, Noema Pharma is a biotechnology company based in Basel, Switzerland. It specializes in developing innovative therapies for orphan neurological disorders characterized by imbalanced neuronal networks, aiming to improve patient outcomes and quality of life.
NUA Surgical
Series A in 2024
NUA Surgical is an award-winning company based in Galway, Ireland, developing and manufacturing surgical instruments for obstetrics and gynecology. Its patented disposable C-section retractor is designed to improve ergonomics and safety during caesarean deliveries, aiming to reduce complications and support safer care for mothers and infants.
Ju:niz Energy
Acquisition in 2024
Ju:niz Energy, based in Aschheim, Germany, specializes in developing sustainable real estate and renewable energy solutions. The company constructs eco-friendly residential and commercial properties, complemented by large-scale energy storage systems and local energy centers, all adhering to technical standards.
Calisen
Acquisition in 2024
Calisen plc is a company based in Manchester, United Kingdom, that owns and manages essential energy infrastructure assets. It operates through two primary business units: Calvin Capital and Lowri Beck. Calvin Capital focuses on procuring, owning, and managing a portfolio of electricity and gas meters, primarily smart meters, for energy retailers. Meanwhile, Lowri Beck provides installation, meter reading, maintenance services, and ancillary support, such as customer service and call center operations, also on behalf of energy retailers. Calisen aims to capitalize on the UK government's initiative to roll out smart meters and is committed to supporting a cleaner and more sustainable energy sector by offering innovative services, including electric vehicle charging solutions. The company was incorporated in 2020.
ATB Therapeutics
Series A in 2024
ATB Therapeutics is a biopharmaceutical company that provides novel therapeutic solutions and treatments for cancer patients.
PageUp
Acquisition in 2024
PageUp People Limited is a provider of a cloud-based talent management platform designed to assist organizations in effectively managing various human resource functions. Founded in 1980 and headquartered in Melbourne, Australia, the company offers a comprehensive suite of services that includes recruitment, onboarding, performance management, learning and development, succession planning, and analytics. Its platform enables clients to streamline their talent management processes, providing tools for hiring, employee training, and career tracking. PageUp serves a diverse range of clients, including major organizations such as AEGIS, AngloAmerican, and National Australia Bank, and has established additional offices in Sydney, Singapore, Hong Kong, New York, and London.
Neara develops predictive modeling software for utilities to proactively manage their networks. Its platform simulates severe weather scenarios, assesses network vulnerabilities, and enables informed decision-making.
Vinted
Secondary Market in 2024
Vinted is an online marketplace that focuses on promoting second-hand fashion as a preferred choice for consumers. The platform allows users, primarily targeting girls and women, to buy, sell, and swap clothing, accessories, and lifestyle items in a peer-to-peer environment. Vinted enhances the shopping experience by incorporating an online chatting feature, facilitating communication between users and making transactions simpler and more efficient. With a mobile-first approach, Vinted aims to make second-hand shopping accessible and cost-effective for its community.
OX2 is a company focused on providing renewable energy solutions, including the development and sale of wind and solar farms. They operate in several countries across Europe, such as Sweden, Finland, Poland, France, Lithuania, Norway, Spain, Italy, Estonia, and Romania. In addition to their core activities in solar and onshore and offshore wind farms, OX2 is also involved in energy storage projects and the development of hydrogen solutions. The company emphasizes technical and business management solutions to support its various energy initiatives.
Sequana Medical
Post in 2024
Sequana Medical is a Swiss medical device company based in Zurich that specializes in developing and commercializing implantable pump systems to manage fluid balance within the body. The company's flagship product, the Alfapump System, is designed to automatically and continually remove ascites, which is excess fluid that accumulates in the abdominal cavity due to advanced liver disease, certain cancers, or congestive heart failure. This system moves the excess fluid to the bladder for natural elimination through urination. Sequana Medical's technology also has potential applications in managing pleural effusions in lung disease patients and fluid overload in those with end-stage renal disease and congestive heart failure. The company was founded in 2006 and has additional offices in Munich, Germany.
Indostar Home Finance
Acquisition in 2024
Indostar Home Finance is a housing finance company that provides mortgages to retail clients in tier 2 to tier 4 cities and has supported low-income homeowners and small companies.
PanTera focuses on the large-scale production of actinium-225, a promising radioisotope for targeted cancer therapies. The company aims to improve accessibility to personalized nuclear medicine treatments while ensuring sustainability through the recycling of materials in their production process.
GeBBS Healthcare Solutions
Acquisition in 2024
GeBBS Healthcare Solutions is a technology-enabled company that provides revenue cycle management (RCM) solutions to improve financial performance, compliance, and patient satisfaction. Founded in 2005 and headquartered in Culver City, California, GeBBS offers a range of services including Health Information Management (HIM), Revenue Cycle Management (RCM), Patient Access, Risk Adjustment Solutions, strategic outsourcing, and consulting services. The company serves hospitals, physician groups, health plans, and medical billing companies. With over 6,000 employees globally, GeBBS has formed strategic partnerships with various industry associations and organizations.
Compass Education
Private Equity Round in 2024
Compass Education is a provider of a cloud-based school management platform designed to enhance operational efficiency for educational institutions. Serving customers primarily in Victoria, New South Wales, Brisbane, and Dublin, the platform features a multilingual and multi-currency student information system. It offers a comprehensive suite of modules that address critical areas such as attendance tracking, reporting, parent communication, student well-being, learning management, staff development, online payments, event management, and data analytics. By streamlining these processes, Compass Education enables schools to reduce administrative burdens, allowing administrators to focus on engaging with the school community and delivering high-quality learning experiences.
PropertyGuru
Acquisition in 2024
Founded in Singapore in 2006, PropertyGuru operates online property marketplaces across Southeast Asia. It connects agents and developers with property seekers for residential and commercial properties, serving over 4.5 million consumers annually.
KJ Environment
Acquisition in 2024
KJ Environment is an environmental and energy infrastructure specialist is establishing a scaled and diverse end-to-end waste treatment platform focusing on plastic recycling and waste-to-electricity conversion.
AMCS Group
Acquisition in 2024
AMCS Group is an Irish company specializing in integrated software and technology solutions for the waste, recycling, and resource management industries. Established in 2002 by James Martin and Austin Ryan, AMCS offers a range of products including weighing and RFID technology, mobile computing solutions, and ERP software designed to optimize business processes and improve customer service.
Acronis
Acquisition in 2024
Acronis, Inc. is a global provider of backup software, disaster recovery, and secure data access solutions, catering to consumers, small to medium-sized businesses, and enterprises. Established in 2000 and headquartered in Woburn, Massachusetts, Acronis offers a comprehensive range of services, including physical, virtual, and cloud server backup solutions, as well as storage management and secure file sharing. The company's innovative Acronis AnyData engine delivers protection across various devices and environments, while its Acronis Cyber Protect solution integrates data protection with cybersecurity to address safety, accessibility, privacy, authenticity, and security challenges. Acronis employs advanced technologies, including AI-driven anti-malware and blockchain-based data authentication, to safeguard data in cloud, hybrid, and on-premises settings. With a workforce of over 2,000 employees and a presence in 45 locations, Acronis serves a diverse clientele across sectors such as public services, healthcare, and publishing, supporting more than 750,000 businesses worldwide.
Asceneuron
Series C in 2024
Asceneuron is a biotechnology company dedicated to discovering and developing therapeutics for neurodegenerative disorders with high unmet medical needs. It focuses on orphan tauopathies, Alzheimer's disease, and Parkinson's disease.
FlixBus
Private Equity Round in 2024
FlixBus, operated by FlixMobility, is a notable provider of intercity travel, focusing on affordable, convenient, and environmentally-friendly transportation solutions. Since its inception in 2013, the company has established Europe's largest long-distance bus network and introduced green long-distance trains in 2018, alongside a pilot for all-electric buses in Germany and France. The platform offers travelers a sustainable alternative to private transportation, featuring amenities such as free WiFi, flexible online booking, and innovative ticketing systems. FlixBus also expanded its services to the United States in 2018, bringing its unique travel model to a broader audience. By collaborating with regional bus partners and private train companies, FlixMobility combines technological innovation with traditional transportation expertise, positioning itself as a leader in the evolving mobility landscape. As a result, FlixBus has transformed the travel experience for over 100 million people across Europe and the United States while contributing to job creation in the mobility sector.
Vico Therapeutics
Series B in 2024
Vico Therapeutics B.V. is a biotechnology company based in Leiden, the Netherlands, founded in 2019. The company specializes in the development of RNA modulating therapies aimed at treating rare neurological disorders. Vico Therapeutics focuses on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome, which encompass a range of hereditary and neurodevelopmental disorders. By discovering and developing innovative therapies, the company aims to address significant unmet medical needs in the central nervous system, providing new treatment options for patients and healthcare professionals.
Peak3 develops insurtech software offering digital insurance solutions tailored for on-demand customers. Their platform enables businesses to integrate relevant protection within customer journeys, redefining the insurance landscape through digital ecosystems.
Perficient
Acquisition in 2024
Perficient is an information technology consulting and software engineering firm that provides software development and digital consultancy services, IT strategy, and implementation support. The company helps clients leverage Internet-based technologies to improve productivity, competitiveness, and efficiency while strengthening relationships with customers, suppliers, and partners and reducing IT costs. Its offerings include big data analytics, technology platform deployments, enterprise content management, portals and collaboration, management consulting, custom applications, business integration, business process management, and customer relationship management. It serves the healthcare, financial services, retail, and electronics industries.
WSO2 Inc. is a developer of an open-source enterprise middleware platform that facilitates digital transformation for organizations worldwide. Founded in 2005 and headquartered in Mountain View, California, with additional offices across various countries, WSO2 provides tools for enterprise architects to build, integrate, manage, secure, and analyze APIs, applications, and microservices across diverse environments, including on-premises and cloud settings. The company's offerings include WSO2 Developer Studio, WSO2 Private PaaS, and WSO2 App Cloud, which support application development and hosting, as well as customer identity and access management solutions. WSO2's API-first approach enables organizations to efficiently harness their APIs, enhancing user experiences while managing over 1 billion identities and executing trillions of transactions annually. The company serves multiple sectors, including healthcare, finance, retail, and technology, positioning itself as a significant player in the digital landscape.
Universidad Europea
Acquisition in 2024
Universidad Europea is an innovative higher education institution focused on enhancing societal value and progress. It operates a network of schools and educational facilities that offer a range of undergraduate and graduate programs designed to meet the demands of today’s job market. By providing an international and tailored educational experience, Universidad Europea aims to equip students with the skills and knowledge necessary for personal and professional success. The institution is dedicated to building the future of higher education through its commitment to quality and relevance in its academic offerings.
Binx Health Limited is an in vitro diagnostics company based in Trowbridge, United Kingdom, founded in 2005. The company specializes in developing diagnostic instruments and disposable cartridge systems for decentralized laboratory and point-of-care settings. Its flagship product, the binx io platform, is the first FDA-cleared, CLIA-waived system for detecting chlamydia and gonorrhea in both males and females, delivering results comparable to central laboratory performance within approximately thirty minutes. Binx Health aims to enhance healthcare access by addressing traditional barriers and extending outreach through its point-of-care diagnostic solutions. The company also focuses on providing rapid polymerase chain reaction (PCR)-based results and a comprehensive digital program that includes evidence-based testing, counseling, treatment, and follow-up services. Binx Health has established a strategic partnership with Sherlock Biosciences, further strengthening its commitment to improving community health outcomes.
Avetta
Acquisition in 2024
Avetta develops a SaaS platform for managing suppliers, contractors, and vendors. It offers solutions like PICS Organizer for information collection and analysis, DocuGUARD for form verification, InsureGUARD for insurance certificate review, AuditGUARD for various audits, EmployeeGUARD for employee-level assessments, Enterprise Organizer for improved communication, and GUARDBuilder for custom contractor tracking. Serving industries such as oil and gas, chemical, manufacturing, and government worldwide.
Onward is a medical technology company focused on developing therapies aimed at enabling functional recovery for individuals with spinal cord injuries. The company is creating an Implantable Neuro-stimulation System (INS) that features real-time motion feedback and utilizes training tools for rehabilitation. Onward has developed two platforms for neurostimulation: ARCIM, an implantable system, and ARCEX, a non-invasive transcutaneous system. To establish its customer base, Onward has targeted the United States and four European markets, namely Germany, France, the United Kingdom, and the Netherlands.
Tubulis GmbH, founded in 2019 and based in Munich, Germany, specializes in the research, design, and development of protein-drug conjugates, particularly focusing on antibody-drug conjugates (ADCs). The company aims to create transformative chemotherapeutic medications that are tailored to combat cancer and chronic diseases. By integrating proprietary technologies with disease-specific biology, Tubulis develops unique protein-drug combinations that enable clinicians to treat patients while minimizing the adverse effects typically associated with traditional chemotherapy. Through its innovative approach, Tubulis seeks to improve therapeutic outcomes and enhance the safety of cancer treatments.
Phagenesis
Series D in 2024
Phagenesis develops a medical device for treating dysphagia, a swallowing disorder often resulting from stroke or brain injury. The device, Phagenyx, uses neurostimulation therapy to harness the brain's capacity for relearning lost functions via neuroplasticity. It consists of a base station and a catheter inserted through the nose, delivering optimal stimulations to the pharynx while recording patient data.
Believe is a digital distributor focused on supporting independent musicians and labels. It offers expertise, fairness, transparency, and respect throughout the digital distribution process.
Onera Health
Series C in 2024
Onera Health, Inc. specializes in sleep diagnostic solutions and services aimed at identifying sleep disorders such as insomnia, sleep apnea, and narcolepsy. Founded in 2017 and headquartered in Palo Alto, California, with a research and development office in Eindhoven, the Netherlands, the company utilizes advanced sleep diagnostic patch systems that collect and analyze sleep data. These innovative solutions are designed to enhance patient care by providing comprehensive sleep test data to healthcare professionals across various settings, thereby improving the management of sleep-related ailments and potentially benefiting other medical fields through remote monitoring of chronic conditions. Onera Health's mission is to improve the health and quality of life for individuals struggling with sleep issues while also contributing to cost reductions in healthcare.
InstaVolt
Private Equity Round in 2024
InstaVolt Ltd is a UK-based company that specializes in the development, construction, ownership, and operation of electric vehicle (EV) charging stations. Incorporated in 2016 and headquartered in Basingstoke, InstaVolt is committed to enhancing the accessibility and convenience of EV charging across the country. The company installs and maintains rapid charging units at various locations, including retail and food service sites, allowing landowners to generate rental income while providing EV drivers with efficient charging options. InstaVolt operates on an open charger model, enabling users to access charging points on a pay-as-you-go basis without the need for subscriptions or membership cards. With a focus on improving air quality and reducing carbon emissions, InstaVolt aims to alleviate range anxiety, a significant barrier to EV adoption, by ensuring that rapid charging points are readily available throughout the UK.
Vico Therapeutics
Series B in 2024
Vico Therapeutics B.V. is a biotechnology company based in Leiden, the Netherlands, founded in 2019. The company specializes in the development of RNA modulating therapies aimed at treating rare neurological disorders. Vico Therapeutics focuses on conditions such as spinocerebellar ataxias, Huntington’s disease, and Rett syndrome, which encompass a range of hereditary and neurodevelopmental disorders. By discovering and developing innovative therapies, the company aims to address significant unmet medical needs in the central nervous system, providing new treatment options for patients and healthcare professionals.
Indium Software
Acquisition in 2023
Indium is a rapidly expanding company specializing in AI-driven digital engineering services. They focus on developing innovative solutions across applications and data, with expertise in Generative AI, Data Engineering, AI/ML, Low-Code Development, and Quality Engineering.
HVD Group
Private Equity Round in 2023
HVD Group offers cloud-based end-to-end field service management and enterprise resource planning software with key functionalities such as order, project and asset management, scheduling, time reporting, procurement and documentation handling.
Next One Technology
Private Equity Round in 2023
Next One Technology operates within the cloud management and information technology sectors, focusing on the construction, contracting, and service industries. The company develops cloud-based systems, including Next Project and Next Field, which are designed to streamline project administration and enhance control over financial and payroll processes for businesses of all sizes. By providing user-friendly tools and environments, Next One Technology aims to improve efficiency, facilitate growth, and increase profitability for its clients. Additionally, the company is dedicated to making technology education accessible, offering resources that enable individuals to learn tech skills and upskill software teams, thus simplifying developer workflows.
Zeus Industrial Products
Acquisition in 2023
Zeus Industrial Products is a manufacturer specializing in polymer extrusion and material science innovation. The company provides a diverse range of products, including fluoropolymers, custom extruded items, and specialized heavy construction products. Additionally, Zeus offers heavy wall and convoluted products, as well as PTFE and FEP heat shrink products. Their expertise in these areas positions them as a key player in the polymer industry, catering to various industrial needs.
LUMA Vision
Series A in 2023
LUMA Vision develops connected intravascular medical devices to support the treatment of cardiac arrhythmias. Using advanced four-dimensional imaging and artificial intelligence with real-time tissue analysis, the company enhances electrophysiology and structural heart interventions, aiming to improve patient outcomes, increase procedural safety, and reduce healthcare system costs.
Shinobi Therapeutics
Series A in 2023
Shinobi Therapeutics is a biotechnology company dedicated to developing innovative cell therapies that utilize hypoimmune CD8αβ induced pluripotent stem cells (iPS-T cells) to enhance cancer treatment and address other diseases. The company's advanced immune evasion technology aims to improve the effectiveness and accessibility of these therapies, ultimately reducing costs and enhancing patient outcomes. By focusing on durable responses and the potential for redosing, Shinobi Therapeutics strives to provide the healthcare industry with comprehensive immune therapies that can address a range of diseases, including cancer and genetic disorders.
Arcwood Environmental
Acquisition in 2023
Heritage Environmental Services is a privately held environmental services firm based in Indianapolis, Indiana, with over 45 years of experience in the industry. The company specializes in providing a range of environmental management and consultancy services. Its offerings include waste treatment, landfill disposal, logistics, laboratory testing, industrial maintenance, and regulatory training. Heritage is committed to assisting clients in navigating environmental challenges while ensuring compliance with regulations and promoting sustainable practices.
HRBrain
Acquisition in 2023
HRBrain, Inc. is a Tokyo-based company founded in 2016 that specializes in providing cloud-based human resource evaluation services. It operates an online platform designed to streamline the management and assessment of employee goals, offering centralized management of human resource data, personal evaluations, and organizational structure analysis. The platform enables businesses to visualize and analyze accumulated evaluation data, facilitating effective personnel evaluation and management of interview logs and target sheets. By leveraging its technology, HRBrain assists companies and HR professionals in developing strategic management measures to enhance workforce performance.
Nouscom is a biotechnology company focused on developing an immunotherapy platform that creates engineered viral vector vaccines for cancer treatment. The company's innovative platform leverages a portfolio of modified viral vectors, specifically designed for the efficient expression of long strings of tumor neoantigens. This approach is complemented by a toolkit that facilitates the induction of robust antitumor T-cell responses, effectively enhancing cancer-specific cellular immunity in patients. Through its research and development efforts, Nouscom aims to improve cancer treatment outcomes by harnessing the body's immune system to target and combat cancer cells.
Statera Energy
Acquisition in 2023
Statera Energy is a UK-based company engaged in the development, ownership, and operation of energy infrastructure. Its portfolio comprises energy storage facilities and high-efficiency gas reciprocating engines, all developed and managed in-house from construction through operation. The company's primary objective is to enhance flexibility within the UK electricity system, supporting national grid operators, distribution network operators (DNOs), and energy wholesalers in their transition towards a low-carbon future.
MinervaX
Venture Round in 2023
MinervaX is a biotechnology company focused on developing maternal vaccines to prevent infections caused by Group B streptococcus (GBS), which can lead to serious adverse pregnancy outcomes and life-threatening conditions for newborns. The company leverages a specific fusion protein that has shown promise in eliciting protective immunity against various clinically relevant GBS strains. By concentrating on this innovative vaccine approach, MinervaX aims to provide medical professionals with effective tools to safeguard newborns from bacterial infections, ultimately enhancing maternal and infant health outcomes.
AgomAb Therapeutics
Series C in 2023
AgomAb Therapeutics N.V., based in Gent, Belgium, specializes in the development of molecular therapies aimed at regenerating damaged tissues. The company focuses on creating agonistic monoclonal antibodies, known as agomAbs, which are designed to stimulate molecular and cellular repair mechanisms. These therapies have the potential to restore organ function in patients suffering from fibrotic, inflammatory, autoimmune, and degenerative diseases. AgomAb targets biologically validated pathways, including Transforming Growth Factor β and Hepatocyte Growth Factor, while employing specialized capabilities in organ-specific small molecules and high-affinity antibodies. The company boasts a diversified clinical pipeline addressing various fibrotic conditions and possesses comprehensive research and development expertise, alongside a strong track record in business development.
VetPartners
Acquisition in 2023
VetPartners empowers their people to perform through education, guidance, support, simple processes and respectful relationships. They foster and create connection across their own network and the wider industry they work in. They are committed to doing what is right, being empathetic and supportive.
AstronauTx
Series A in 2023
AstronauTx focuses on restoring healthy function of astrocytes, a type of brain cell crucial for neuronal health and blood-brain barrier integrity. Its primary goal is to develop treatments targeting astrocyte dysfunction in dementias like Alzheimer's disease.
Wellhub is a corporate wellness platform designed to enhance employee engagement through improved physical activity. The company connects organizations with a diverse network of partners focused on fitness, emotional well-being, nutrition, and mindfulness. By offering a comprehensive subscription service, Wellhub enables employees to access various wellness options that promote lasting behavioral change and foster a healthier work environment. With over 2,000 clients, Wellhub is recognized for its ability to drive individual performance and overall business success by revolutionizing how employees engage in physical activity.
Xeltis is a clinical-stage medical device company developing bio-absorbable heart valves and blood vessels. Its RestoreX technology enables the body's natural healing system to create functional tissue within its devices, forming new valves or vessels over time. Headquartered in Zurich, Switzerland, with R&D and manufacturing facilities in Eindhoven, Netherlands, Xeltis aims to transform cardiovascular care.
Dechra Pharmaceuticals
Acquisition in 2023
Dechra Pharmaceuticals PLC is a prominent developer and manufacturer of veterinary pharmaceuticals and related products, focusing on improving animal health and welfare. The company operates through three main segments: European Pharmaceuticals, North American Pharmaceuticals, and Pharmaceuticals Research and Development. It provides a diverse range of products, including endocrinology, dermatology, analgesia, and anesthesia treatments for dogs and cats, as well as antibiotics and vaccines for poultry, pigs, and cattle. Additionally, Dechra offers nutrition products aimed at addressing various health conditions in pets, such as allergies and obesity. The company also distributes veterinary pharmaceuticals and equipment and provides related training and support services. Founded in 1997 and headquartered in Northwich, the United Kingdom, Dechra Pharmaceuticals markets its products through a network of wholesalers and distributors, emphasizing its commitment to enhancing animal health globally.
VarmX is a pharmaceutical spin-off from the Leiden University Medical Center, focused on the development and manufacturing of therapeutic proteins aimed at restoring blood clotting in patients experiencing bleeding. The company's lead product, PseudoXa, is a modified recombinant human coagulation factor X that can promptly reinstate blood clotting in patients using direct factor Xa anticoagulants, such as rivaroxaban, apixaban, and edoxaban. These anticoagulants, commonly prescribed for the prevention and treatment of thrombosis and stroke, often lead to severe bleeding as a side effect. PseudoXa addresses this critical issue by effectively stopping and preventing bleeding, thereby enhancing the safety of anticoagulant therapy for millions of patients worldwide.
Evommune, Inc. is a biotechnology company based in Los Altos, California, that develops and manufactures tissue-based medicines for inflammatory diseases. Incorporated in 2020, Evommune focuses on creating novel strategies to treat these disorders by addressing both symptoms and the underlying causes, thereby halting disease progression. The company employs a proprietary tissue-based platform that accelerates the discovery of innovative treatments, enhancing the potential for clinical success. With a commitment to improving the quality of life for patients, Evommune's pipeline includes initiatives aimed at tackling a range of prevalent inflammatory illnesses, positioning the company as a leader in advancing therapies in the fields of immunology and dermatology.
Noya is a company focused on combating climate change through innovative carbon capture technology. By retrofitting existing industrial cooling towers, Noya integrates a non-toxic chemical blend that efficiently captures carbon dioxide without requiring physical alterations to the equipment. This approach allows industries to reduce their carbon footprints while simultaneously generating a valuable resource, as the captured CO2 is sold to companies that utilize it as a raw material. Noya's mission is to accelerate the global transition towards a carbon-negative future, positioning itself as a key player in the development of sustainable solutions for environmental challenges.
Lazer Logistics
Acquisition in 2023
Lazer Logistics specializes in outsourced yard management services, focusing on trailer movements within customer yards. They offer turnkey solutions, including equipment provision, customized solutions, and safe trailer movement around production and distribution sites.
GotPhoto
Acquisition in 2023
GotPhoto is a company that offers a software-as-a-service (SaaS) platform designed specifically for photographers, particularly those specializing in school and volume photography. By providing an efficient workflow and e-commerce solutions, GotPhoto enables photographers to sell their photos online seamlessly. The platform simplifies the process of managing photo sales, allowing photographers to focus on their creative work while effectively reaching their customers. With its user-friendly interface and tailored features, GotPhoto positions itself as a key player in the photography industry, facilitating online transactions and enhancing the overall experience for both photographers and their clients.
Tion Renewables
Acquisition in 2023
Tion Renewables is a company engaged in the production of alternative energy, specializing in the development and management of a diverse portfolio of renewable energy plants. It operates wind and solar farms across Europe, contributing to the generation of cleaner energy. By focusing on onshore wind and photovoltaic power plants, Tion Renewables supports clients in their transition toward sustainable energy solutions, aligning with global efforts to enhance the use of renewable resources. The company's initiatives reflect a commitment to promoting a greener future through its strategic investment in renewable energy infrastructure.
IntegrityNext
Venture Round in 2023
IntegrityNext is a Munich-based company founded in 2016 by Martin Berr-Sorokin that specializes in supply chain compliance and sustainability monitoring. The company offers a cloud-based platform that enables businesses to oversee their suppliers' compliance with regulatory requirements, thereby reducing risk. Its platform automates the collection of supplier self-assessments and certificates, while also monitoring social media for potential malpractice and reputational threats. With features such as automated risk alerts, a pre-built supplier questionnaire, and a real-time dashboard, IntegrityNext assists small and medium-sized enterprises in translating complex compliance data requirements from international regulations into effective processes and systems. This comprehensive approach to supply chain compliance supports organizations in achieving greater transparency and accountability in their operations.
QurAlis Corporation
Series B in 2023
QurAlis Corporation is a Cambridge, Massachusetts-based clinical-stage biotechnology company developing precision therapeutics for amyotrophic lateral sclerosis and other neurodegenerative diseases. It focuses on drugs that directly target disease-causing genetic alterations using proprietary platforms and biomarkers to identify and treat patients with specific genetic mutations, aiming to halt disease progression and improve outcomes.
SK Shielders
Acquisition in 2023
SK Shielders, operating under ADT Caps Co. Ltd., is a prominent security service provider in South Korea, established in 1971 and headquartered in Seoul. The company specializes in machine security, personnel guarding, security monitoring, and dispatch services, catering to a diverse clientele that includes households, commercial establishments like restaurants and offices, and various business sectors. With a subscriber base of 570,000, SK Shielders stands as the second-largest security firm in the country, following Samsung's S-One. In addition to traditional security services, the company also offers building maintenance and fire prevention solutions, reinforcing its comprehensive approach to safety and security.
Radius Global Infrastructure
Acquisition in 2023
Radius Global Infrastructure, Inc., headquartered in New York, specializes in the ownership and leasing of essential communications properties for wireless carriers and tower companies. Through its subsidiary, AP Wireless, the company manages a portfolio of ground, rooftop, and other critical sites that support the infrastructure necessary for cell site antenna systems. As of mid-2020, Radius held interests in approximately 6,600 leases across about 5,000 communication sites in the United States and 18 additional countries. Recognized as a significant international aggregator of rental streams in the wireless communications sector, Radius Global Infrastructure focuses on acquiring and managing telecom real property interests, which provides its clients with opportunities to expand into adjacent digital infrastructure markets.
Xeltis is a clinical-stage medical device company developing bio-absorbable heart valves and blood vessels. Its RestoreX technology enables the body's natural healing system to create functional tissue within its devices, forming new valves or vessels over time. Headquartered in Zurich, Switzerland, with R&D and manufacturing facilities in Eindhoven, Netherlands, Xeltis aims to transform cardiovascular care.
va-Q-tec
Acquisition in 2023
va-Q-tec is a high-tech company established in 2001, specializing in innovative insulation solutions, particularly through vacuum insulation panels (VIPs). The company's products are designed to enhance energy efficiency and are environmentally friendly, making them suitable for various applications. va-Q-tec's technology significantly reduces energy costs in diverse sectors, including the transportation of pharmaceutical products, refrigeration and freezing appliances, construction, and automotive and aerospace industries. The company operates through several segments, with a strong presence in Germany and across the European Union. Its customer base spans multiple industries, including healthcare, logistics, appliances and food, construction, and technical sectors.
Cardiac Dimensions
Series D in 2023
Cardiac Dimensions, Inc. is a medical device company focused on developing innovative minimally invasive treatments for heart failure and associated cardiovascular issues. Founded in 2000 and headquartered in Kirkland, Washington, with additional operations in Sydney, Australia, and Offenbach, Germany, the company is known for its Carillon Mitral Contour System. This permanent implant is designed specifically for the treatment of functional mitral regurgitation, utilizing a catheter-based approach to reshape the mitral valve and effectively reduce regurgitation. By providing a non-surgical option for patients, Cardiac Dimensions aims to improve outcomes for those suffering from heart-related conditions.
Saur SAS
Acquisition in 2023
Founded in 1933, Saur SAS is the third largest company in France’s water distribution and wastewater management sector. It supplies drinking water to millions of residents and manages wastewater treatment across the country. In addition to these core services, the company has expanded into municipal waste collection and treatment, and provides ancillary services to local authorities.
Ontinue
Acquisition in 2023
Ontinue is a developer of a security operations platform that specializes in AI-powered Managed Extended Detection and Response (MXDR) services. The company's platform harnesses artificial intelligence to enhance security by localizing incidents, streamlining communication, and delivering prevention services. This approach enables clients to improve operational efficiency and advance the maturity of their security programs, ultimately providing a comprehensive solution to modern cybersecurity challenges.
Madison Energy Infrastructure
Acquisition in 2022
Madison Energy Infrastructure is a platform that creates, owns, and manages renewable energy projects. The company develops energy generation projects to unlock the clean energy asset class to institutional investors. It specializes in the development, construction and operation of distributed generation assets within the commercial and industrial (C&I) and small utility-scale sectors.
Cirba Solutions
Private Equity Round in 2022
Cirba Solutions specializes in battery recycling services, catering to corporations, governments, municipalities, and households. The company collects end-of-life batteries and processes them to extract critical materials, which are then reintroduced into the supply chain using a circular economy model. This approach minimizes waste and promotes environmental compliance through advanced technological processes. Cirba Solutions offers comprehensive services including battery inventory management, de-installation, project management, recycling systems, and accessories for damaged batteries. These solutions help clients meet regulatory requirements and divert waste from landfills while ensuring the safe recycling of each component.
SHL Medical
Secondary Market in 2022
Founded in 1989, SHL Medical specializes in designing, developing, and manufacturing advanced drug delivery systems. These include auto injectors, pen injectors, and inhalers for global pharmaceutical and biotechnology companies.
Trescal
Acquisition in 2022
Trescal specializes in calibration and asset management services, offering a range of multi-brand solutions across various metrological domains. The company operates independently from original equipment manufacturers (OEMs), providing clients with calibration services that are designed to improve industrial performance. Trescal’s services are available both on-site and in dedicated laboratories, ensuring compliance with International Organization for Standardization (ISO) standards. By focusing on enhancing measurement processes, Trescal supports clients in achieving greater accuracy and efficiency in their operations.
Founded in 2005, Storytel is a leading provider of audiobook and e-book streaming services, offering unlimited access to consumers across over 20 markets. The company's extensive library includes books in multiple languages, catering to diverse reading preferences.
Developed, tested, and proven in Germany, Vara is a leading AI-powered breast cancer screening company on a mission to find every deadly breast cancer early. Vara’s Artificial Intelligence (AI) technology is embedded within the German Breast Cancer Screening Program and is backed by some of the most respected institutions in breast cancer screening in the world including Cambridge (UK), Memorial Sloan (US), and Karolinska (Sweden). Vara’s clinical evidence has also been published in Lancet Digital Health, demonstrating that Vara-assisted radiologists significantly outperform average radiologists and are able to find cancers that would otherwise have been missed. Vara works with healthcare stakeholders, radiology service providers, and medical doctor networks to improve access to high-quality screening in Germany, Egypt, India and Mexico.
Billtrust
Acquisition in 2022
Billtrust is a cloud-based provider of accounts receivable and integrated payment processing solutions that digitally transform B2B payments and order-to-cash processes. The platform covers credit decisioning and monitoring, online ordering, invoicing, cash application, and collections, enabling faster payment cycles and improved cash flow. Its solutions integrate with ERP systems, financial institutions, and accounts payable software, helping customers move from paper invoicing and checks to electronic billing and payments. By accelerating revenue recognition and reducing manual and paper-based tasks, Billtrust aims to deliver cost savings and a better user experience for businesses managing B2B commerce.
etherna immunotherapies
Series B in 2022
eTheRNA Immunotherapies NV is a Belgium-based biotechnology company that specializes in the development of mRNA-based immunotherapies. Founded in 2013 and located in Niel, the company focuses on harnessing the immune system's dendritic cells to create treatments for melanoma, triple-negative breast cancer, and infectious diseases. eTheRNA has developed innovative TriMix technology that enhances the immune response, enabling patients to better combat these diseases. The company aims to be a leader in nucleic acid-based medicines, collaborating with partners to facilitate the creation of new drugs and improve patient outcomes. Additionally, eTheRNA has established a strategic partnership with China Grand Pharmaceutical and Healthcare Holdings Limited to further its mission.
FundamentalVR
Series B in 2022
FundamentalVR have been working with leading pharmaceutical companies to combine virtual and mixed reality with haptic feedback using their ‘FeelRealVR’ platform to create simulated surgical procedures to help educate and train healthcare professionals.
The company works at the nexus of haptics, machine learning, and immersive technologies (XR).
FundamentalVR was established in 2012 by Chris Scattergood in London, England.
United Talent Agency
Secondary Market in 2022
United Talent Agency (UTA) is a talent and entertainment agency that represents actors, writers, directors, recording artists, and corporate brands across various industries such as film, television, music, digital media, and more. With a roster of high-profile clients including Johnny Depp, Harrison Ford, Jennifer Lopez, and many others, UTA specializes in providing representation for individuals and companies in the entertainment industry. In addition to talent representation, UTA also works with emerging technology companies and offers services in intellectual property, computer and video games, commercials, voiceovers, endorsements, and entertainment marketing.
Xilis, Inc. is a biotechnology company founded in 2019 and based in Chapel Hill, North Carolina. The company specializes in developing next-generation organoid technologies aimed at guiding precision therapy for cancer patients and enhancing drug discovery processes. Its flagship platform, XilisµO, facilitates rapid diagnostics, personalized drug screening, and the creation of scalable patient-derived models, which support high-throughput drug discovery. By enabling both physicians and pharmaceutical companies to conduct tailored drug screenings, Xilis aims to lower costs and improve treatment outcomes for cancer patients.
SPT Labtech
Acquisition in 2022
SPT Labtech is a manufacturer and designer of automated instrumentation and consumables for life science research. The company specializes in enhancing agility, efficiency, and productivity across various applications, including drug discovery, structural biology, molecular biology, and genomics. Its product portfolio focuses on minimizing assay volumes, streamlining workflows, and reducing material handling costs, thereby empowering life scientists to accelerate their research. SPT Labtech emphasizes collaboration and deep application knowledge, which informs its research and development efforts. The company is committed to addressing existing customer challenges through innovative solutions, driven by a strong ethos of customer-centricity. Additionally, its extensive expertise allows SPT Labtech to manage the entire life cycle of its products, from initial design and engineering to final manufacture and support, ensuring high-quality technical assistance and fostering strong client relationships.
ImCheck Therapeutics
Series C in 2022
Founded in 2015, ImCheck Therapeutics specializes in developing immunotherapeutics targeting members of the butyrophilin super-family for treating a range of autoimmune diseases, with a primary focus on immuno-oncology.
Ariceum Therapeutics
Series A in 2022
Ariceum Therapeutics is a clinical-stage radiopharmaceutical company that focuses on the detection and targeted treatment of aggressive cancers, particularly neuroendocrine tumors and other challenging malignancies. The company's lead product, 177Lu-satoreotide tetraxetan (Satoreotide), acts as an antagonist of the somatostatin type 2 receptor (SSTR2), which is commonly overexpressed in many neuroendocrine tumors. Ariceum is developing Satoreotide as a theranostic pair, which allows for both the diagnosis and targeted radionuclide treatment of neuroendocrine malignancies, certain aggressive tumors, and childhood cancers. This approach aims to provide treatment options for conditions that currently have limited therapies and poor prognoses, enabling healthcare professionals to deliver more effective treatments with reduced side effects.
Envirotainer
Acquisition in 2022
Envirotainer AB specializes in the production, development, and rental of active temperature-controlled containers designed for the air transportation of temperature-sensitive healthcare products. Established in 1986 and headquartered in Upplands Väsby, Sweden, the company has built a reputation as a global leader in secure cold chain solutions for the pharmaceutical industry. Envirotainer provides a range of services, including laboratory testing, qualification and validation support, data collection, and training through its Qualified Envirotainer Program. The company's extensive network includes operations centers in key locations such as Singapore, Dallas, Frankfurt, and Toronto, as well as a station in Hyderabad, India. By leveraging its innovative container solutions and global presence, Envirotainer meets the critical needs of pharmaceutical and biotech clients for reliable shipping solutions that maintain the integrity of temperature-sensitive products.
Redwood Capital Group
Acquisition in 2022
Redwood Capital Group, LLC leverages over 75 years of combined experience in the commercial real estate industry, targeting the acquisition and management of multi-family real estate. Its management team has handled in excess of eight billion dollars of commercial real estate investment, the lion’s share of which has been in multi-family assets. Our mission is to be the foremost choice for institutional and private equity in pursuit of strategic, multi-family investment. We deliver exceptional results to our investors and are uncompromising in our execution of strategy.
Guardian
Acquisition in 2022
Guardian is the local Chinese pest control operator, with a strong presence in Eastern and Southern China.
BPEA EQT
Acquisition in 2022
Established in 1997 and headquartered in Hong Kong, BPEA EQT is a prominent private equity firm with over USD 20 billion in committed capital. The company focuses on buyouts and growth capital investments across Asia Pacific, supporting companies' expansion or acquisitions, and also manages dedicated funds for private real estate and credit.
Ardoq AS, established in 2013 and headquartered in Oslo, Norway, with offices in New York, London, and Copenhagen, specializes in developing solutions to document and visualize complex computer systems. Its flagship product, Ardoq, combines textual documentation with interactive visualizations, offering features such as automatic visualization generation, real-time collaboration, and model-based documentation. Ardoq serves a wide range of professionals, including business users, developers, project managers, and stakeholders, empowering them to understand interdependencies, plan changes, and make data-driven decisions. The platform enables the entire organization to contribute to documentation, fostering a collaborative environment for digital transformation.
LSP is a defense and space company that specializes in providing strategy consulting services. The firm focuses on delivering expert guidance and insights to clients in the defense and aerospace sectors, helping them navigate complex challenges and develop effective strategies. Through its consulting services, LSP aims to enhance the operational efficiency and strategic positioning of its clients within the highly specialized defense and space industries.